EMD-26513

Single-particle
3.1 Å
EMD-26513 Deposition: 26/03/2022
Map released: 11/05/2022
Last modified: 21/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-26513

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7uhf summary report (pdf.gz) Map-7uhf FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution

EMD-26513

Single-particle
3.1 Å
EMD-26513 Deposition: 26/03/2022
Map released: 11/05/2022
Last modified: 21/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Cav1.3
Fitted models: 7uhf

Deposition Authors: Gao S , Yao X , Yan N
Structural basis for pore blockade of human voltage-gated calcium channel Ca v 1.3 by motion sickness drug cinnarizine.
Yao X , Gao S , Yan N
(2022) Cell Res , 32 , 946 - 948
PUBMED: 35477996
DOI: doi:10.1038/s41422-022-00663-5
ISSN: 1001-0602